Article
PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics
27 Aug 2019
Abstract excerpt
BACKGROUND: Advanced stage laryngeal squamous cell carcinoma (LSCC) presents a poor prognosis; thus, there is a great need to identify novel prognostic molecular markers. Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2) is thought to be a novel prognostic factor in several cancers, but its role in LSCC remains unknown. Cancer stem cells (CSCs) are responsible for most instances of tumor recurrence and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
